Spacelabs Healthcare launches Ultrasonic Cardiac Output Monitor in international markets

NewsGuard 100/100 Score

Spacelabs Healthcare today announced the launch of the Ultrasonic Cardiac Output Monitor (USCOM) in several new geographies, including Latin America, Africa, Europe, Australia and Middle East. USCOM’s unique and totally non-invasive method of cardiac monitoring provides an accurate, safe and efficient way of measuring how well the heart is functioning.

“We are pleased to see the strong interest in this new technology and are working hard to spread the news globally of its success in assisting with better patient care,” said Joseph Davin, President, Spacelabs Healthcare North American Operations.

USCOM is the only non-invasive device to provide beat-to-beat performance of both the left and right side of the heart. Portable and user-friendly, USCOM revolutionizes care in all areas, including Emergency, Intensive Care, and general practice. However, USCOM’s most dramatic impact may well be in pediatric intensive care, a population that traditionally could not be safely monitored due to the invasiveness of conventional cardiac output technologies. Now, with USCOM, infants and children can be monitored non-invasively, without risk of infection.

According to Dr. Néstor Hernández, pediatric intensive care physician at Hospital Calvo MacKenna, Santiago, Chile, “USCOM is easy to use and reliable, an excellent tool to assess septic shock in pediatric patients.”

Added Australia’s Dr. Brendan Smith, “This machine is saving lives. No two ways about it.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness